Back to Aberdeen Group plc Aberdeen Group plc

CRBPCRBP
Showing 8 of 10 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in CORBUS PHARMACEUTICALS HOLDINGS INC

Yes. Aberdeen Group holds 1,321,750 shares of CRBP (Corbus Pharmaceuticals Holdings), worth $12.4M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Aberdeen Group has held CRBP since Q1 2024, across 10 quarterly 13F filings.

Current Value

$12.4M

Current Shares

1.3M

Total Value Change

+$11.8M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.3M
0.0%
$12.4M0.0%$9.38
0
2026-Q1
Unchanged
1.3M
0.0%
$12.4M0.0%$9.39
0
2025-Q4
Increased
1.3M
+602.2%
$10.8M0.0%$8.14
45
2025-Q3
Increased
188,231
+160.6%
$2.4M0.0%$12.65
42
2025-Q2
Increased
72,226
+168.6%
$498,3590.0%$6.90
39
2025-Q1
Unchanged
26,894
0.0%
$142,8070.0%$5.31
0
2024-Q4
Unchanged
26,894
0.0%
$317,3490.0%$11.80
0
2024-Q3
Increased
26,894
+422.9%
$554,8230.0%$20.63
39

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used